drugset
drugset / Trial / NCT00277199

Comparability DE vs CD-CHO1

NCT00277199 ↗

Phase 1 Completed 30 enrolled Bristol-Myers Squibb
RandomizedParallel-groupOpen-labelTreatment

Summary

Study to Compare the Pharmacokinetics of CD-CHO1 Process BMS-188667 to DE Process BMS-188667 in Healthy Subjects

Timeline

Start
2002-09
Primary completion
2002-12
Completion
2002-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Abatacept Other / unclassified — —

Indications

No indication recorded.